Results 11 to 20 of about 361,585 (263)
Personalized Regenerative Medicine
Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data.
Babak Arjmand +4 more
doaj +2 more sources
The imperative of the person in personalized medicine. [PDF]
Horwitz RI +5 more
europepmc +4 more sources
Pharmacogenomics and Personalized Medicine [PDF]
Pharmacogenomics is one of the emerging approaches to precision medicine, tailoring drug selection and dosing to the patient’s genetic features. In recent years, several pharmacogenetic guidelines have been published by international scientific consortia, but the uptake in clinical practice is still poor.
Erika Cecchin, Gabriele Stocco
openaire +3 more sources
Personalized Medicine in Allergy [PDF]
Allergic disease is among the most common pathologies worldwide and its prevalence has constantly increased up to the present days, even if according to the most recent data it seems to be slightly slowing down. Allergic disease has not only a high rate of misdiagnosis and therapeutic inefficacy, but represents an enormous, resource-absorbing black ...
Ferrando, Matteo +6 more
openaire +5 more sources
Personalized Medicine: Pharmacokinetics
The “one-size fits all” model that has been used for decades is now replaced by the concept of the “right dose of the right drug for the right patient” [...]
openaire +3 more sources
Personalized medicine in internal medicine
Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of ...
V G, Kukes +12 more
openaire +2 more sources
Translational and Personalized Medicine
The idea behind personalized medicine is to tailor health care to an individual’s unique genetic makeup. Hitherto, “one size fits all” approach was used in medicine. With the rise of personal medicine, we are moving towards a more precise, predictable and powerful medicine that is customized for each individual patient.
Kraljević-Pavelić, Sandra +2 more
openaire +4 more sources
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
Increasing evidence indicates that DNA damage-induced apoptosis suppressor (DDIAS) is an oncogenic protein that is highly expressed in a variety of cancers, including colorectal cancer, lung cancer, breast cancer, and hepatocellular carcinoma (HCC).
Joo-Young Im +3 more
doaj +1 more source
Transcriptomic Analysis of Gene Networks Regulated by U11 Small Nuclear RNA in Bladder Cancer
Small nuclear RNA is a class of non-coding RNA that widely exist in the nucleus of eukaryotes. Accumulated evidences have shown that small nuclear RNAs are associated with the regulation of gene expression in various tumor types.
Zhenxing Wang +23 more
doaj +1 more source
Biobanks and personalized medicine [PDF]
AbstractWe provide a mini‐review of how biobanks can support clinical genetics in the era of personalized medicine. We discuss types of biobanks, including disease specific and general biobanks not focused on one disease. We present considerations in setting up a biobank, including consenting and governance, biospecimens, risk factor and related data ...
J E, Olson +6 more
openaire +2 more sources

